Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2874-2016Class II

LifeCare PCA 3, PCA Serial List Number 12384 Allows for clinician administration or self-administration of...

Abbott Medical / initiated 2013-03-08 / Terminated / root cause: manufacturing process

Hospira Inc. began a recall of LifeCare PCA 3, PCA Serial List Number 12384 Allows for clinician administration or self-administration of analgesic medications on . FDA classified it as Class II and gives the reason as "Screw rotation error occurring when the pump detects a mismatch between the number of steps given to the motor driving delivery and the number of steps the motor actually took. When this malfunction occurs, the pump...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2874-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Abbott Medical
Product
LifeCare PCA 3, PCA Serial List Number 12384 Allows for clinician administration or self-administration of analgesic medications.
Product code
MEA Pump, Infusion, Pca
Reason for recall
Screw rotation error occurring when the pump detects a mismatch between the number of steps given to the motor driving delivery and the number of steps the motor actually took. When this malfunction occurs, the pump will alarm and infusion stops.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Hospira will contract with Stericycle, Inc. in Indianapolis, IN to send letter and a reply form to Hospira, Inc. Receipt of the letters will be confirmed by UPS tracking. Customers will be requested to return a reply form to Stericycle indicating the number of pumps on hand and that they have received the letter and notified their users. In addition, letters will be sent by email to ECRI, NRAC, Noblis and ISMP for notification of their members and posting on their websites. The letter will also be posted to the Hospira website. Letters will be sent to Hospira customers of record who purchased the devices directly from Hospira. Customers will be directed to notify their consignees if they further distributed the product and confirm they have done so. Telephone attempts will be made to contact customers that do not respond in order to confirm receipt of the letter. Final effectiveness will be done as the devices are upgraded with new plastic motors.
Quantity in commerce
69
Distribution
United States (Nationwide) Distribution including Puerto Rico and American Virgin Islands.
Product codes and lots
Serial Number 12921204  12922976  12924008  12925861  12925924  12925998  12928528  12928807  12929016  12929126  12920432  12920820  12920856  12920915  12921404  12921413  12922304  12922976  12925861  12925998  12927215  12929016  12931044  12931141  12931155  12931192  12931244  12931342  12931361  12931413  12931610  12931639  12931649  12931911  12921480  12921487  12923723  12924326  12924350  12924546  12925259  12925447  12926315  12927938  12928075  12928614  12930418  12930709  12930890  12931441  12931760  12931911  12932487  12932717  12920754  12920791  12920897  12921063  12921613  12922062  12923441  12924161  12926859  12927756  12928775  12929346  12929438  12931942  12920112

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2874-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2873-2016Class IITerminatedVoluntary: Firm initiated
Z-2874-2016Class IITerminatedVoluntary: Firm initiated